News and Trends 7 Jun 2022 Yumanity selling neurology assets and merging with Kineta U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate YTX-7739 to Janssen Pharmaceutica NV, and also entering a merger with Kineta, Inc. YTX-7739, as well as Yumanity’s discovery-stage neuroscience product candidates and targets are being sold to Janssen, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, for […] June 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2022 Athersys to restructure – 70% of workforce to go U.S. biotech company Athersys, Inc. has announced a corporate restructuring plan to reduce costs and prioritize its lead clinical programs. In connection with the restructuring, the company is reducing its workforce up to 70%, with most of the reduction expected to be completed by the end of June 2022. The company said this initial step […] June 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2022 ImmunOs Therapeutics raises $74M ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune diseases, has announced the closing of an oversubscribed Series B financing round totaling $74M. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by other new investors Mission BioCapital, GL Capital, PEAK6 Strategic […] June 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2022 Scotland’s industrial biotechnology sector to hit £1B turnover by 2025 Scotland’s industrial biotechnology community is exceeding growth expectations and is on track to achieve annual turnover of £1.2bn ($1.5B) by 2025. This is according to a renewed strategy launched at the Industrial Biotechnology Innovation Centre’s (IBioIC) annual conference this week. The updated National Plan for Industrial Biotechnology outlines new ambitions for Scotland’s bioeconomy, including reaching […] June 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by Biovian 7 Jun 2022 Gene therapy: can CDMOs solve the manufacturing bottleneck? The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for viral vectors and their plasmid building blocks have resulted in a manufacturing bottleneck. Can contract manufacturing organizations cope with the rising demand? In 2019, Zolgensma, a […] June 7, 2022 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2022 Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science 4BIO Capital, an international venture capital firm focusing on the advanced therapies sector, has co-led a $30.3M oversubscribed Series B financing in LUCA Science Inc., which is developing a novel class of mitochondria biopharmaceutical agents. The round was co-led with DCI Partners and existing investor Fast Track Initiative, and supported by existing international investors including […] June 6, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2022 Type 1 diabetes in the crosshairs with Imagine Pharma discovery U.S. biotech company Imagine Pharma is showcasing its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) at the American Transplant Congress in Boston. The company said its industry breakthrough is a critical component for the potential treatment of T1D through autologous cell transplantation. T1D AIPCs are novel cell populations generated and propagated […] June 6, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2022 Report shows growth of life sciences sector in eastern Denmark A new report on the Danish contribution to the Medicon Valley has been published. The report, Life Science in Eastern Denmark – The Danish Part of Medicon Valley is a survey of companies in the sector. Medicon Valley spans the Danish region of Zealand and the Capital Region, and the Skåne region of southern Sweden. […] June 6, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2022 Releasing the microbiome’s potential to restore European soils For decades, soil has been treated as an everlasting food machine rather than as a fragile living thing, and it is reaching a crisis point. Understanding how the soil microbiome interacts with the environment and helping farmers embrace new sustainable methods can have a beneficial impact on the soil, and consequently, our health. After years […] June 6, 2022 - 9 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2022 Upstream Bio to target asthma as it launches with $200M financing Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M Series A financing. The company said the funding will allow it to advance its lead program UPB-101, a clinical-stage monoclonal antibody targeting the thymic stromal lymphopoietin (TSLP) receptor. It added the investment will also help build a pipeline of assets […] June 2, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2022 MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility Singapore biotech firm MiRXES Pte Ltd, which focuses on early detection cancer tests, has opened the first industry 4.0 (i4.0) in vitro diagnostic (IVD) manufacturing facility in Southeast Asia. The S$8M (US$5.8M) 15,000-square-feet facility is located at JTC MedTech Hub. The company said the site is close to the biomedical R&D community at Biopolis, pharmaceutical […] June 1, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2022 Chinese biotech company looks to help global monkeypox drug development Shanghai Zelixir Biotech Company Ltd. has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes, which is the complete set of proteins present at a given time in the cell. The company hopes the predicted structures will help the global quest to develop monkeypox vaccines. Monkeypox cases have grown […] June 1, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email